BioLineRx Presents Final Results from Phase 2a Trial for Relapsed/Refractory AML at SOHO Conference

Go back to BioLineRx Presents Final Results from Phase 2a Trial for Relapsed/Refractory AML at SOHO Conference
Bioline RX Ltd Ordinary shares (AMEX: BLNEF) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High $1.54 
Open $1.64    52 Week Low $1.15 
Day High $0.86    P/E N/A 
Day Low $0.86    EPS $0.00 
Volume 1,500       

Bioline RX Ltd Ordinary shares (AMEX: BLNEF) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High $1.54 
Open $1.64    52 Week Low $1.15 
Day High $0.86    P/E N/A 
Day Low $0.86    EPS $0.00 
Volume 1,500       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.72 -0.04 (1.45%)
Previous Close $2.76    52 Week High $1.63 
Open $2.76    52 Week Low $0.71 
Day High $2.86    P/E N/A 
Day Low $2.70    EPS $0.00 
Volume 9,907       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.72 -0.04 (1.45%)
Previous Close $2.76    52 Week High $1.63 
Open $2.76    52 Week Low $0.71 
Day High $2.86    P/E N/A 
Day Low $2.70    EPS $0.00 
Volume 9,907